Synthesis and evaluation of S-4-(3-thienyl)phenyl-α-methylacetic acid

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 4, 2004, Pages 979-982

  Mittal, Shilpi ^a   Malde, Alpeshkumar ^a   Selvam, C ^a   Arun, K H S ^a   Johar, P S ^a   Jachak, Sanjay M ^a   Ramarao, P ^a   Bharatam, P V ^a   Chawla, H P S ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Arylpropionic acid; Cyclooxygenase; Docking

Indexed keywords

4 (3 THIENYL)PHENYL ALPHA METHYLACETIC ACID; ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IBUPROFEN; METHYL 4 (3 THIENYL)PHENYL ALPHA METHYLACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROPIONIC ACID DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; ENANTIOMER; IN VITRO STUDY; IN VIVO STUDY; ISOMER; MOLECULAR MECHANICS; NONHUMAN; PROTEIN STRUCTURE; RAT; STRUCTURE ANALYSIS; THEORETICAL STUDY;

EID: 0842302972     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.11.066     Document Type: Article

References (22)

1. Cashman J.N. Drugs. 52(suppl.5):1996;13.
2. Hla T., Neilson K. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7384.
3. Ormrod D., Wellington K., Wagstaff A.J. Drugs. 62:2002;2059.
4. Dannhardt G., Keifer W. Eur. J. Med. Chem. 36:2001;109.
5. Wallace J.L. Trends. Pharmacol Sci. 20:1999;4.
6. Agranat I., Caner H., Caldwell J. Nature Rev. Drug. Discov. 1:2002;753.
7. Drugs of Future. 13:1988;411.
8. http://www.pharmabiz.com .
9. Mittal, S.; Johar, P. S.; Chawla, H. P. S. Indian patent Application no. 874/DEL/2002.
10. Roszkowski A.P., Rooks W.H. II, Tomolonis A.J., Miller L.M. J. Pharmacol. Exp. Ther. 179:1971;114.
11. Sastry C.V.R., Marwah A.K., Marwah P., Rao G.S., Shridhar D.R. Synthesis. 11:1987;1024.
12. Marwah P., Marwah A.K., Rao G.S. Synth. Comm. 19:1989;2809.
13. Kumar, M. A.; Reddy, S. C. V.; Rai, S. D.GB 2,181,728, 1987; Chem. Abstr. 1988, 108 94374.
14. Sone T., Inoue M., Sato K. Bull. Chem. Soc. Jpn. 61:1988;3779.
15. 87 mp: 182°C).
16. 4 and evaporated to dryness to give S-1b. The ratio of the two enantiomers of 1b was determined by (R,R) Whelk-O 1 with 98/2/0.1 hexane/isopropyl alcohol/acetic acid as mobile phase using UV detector at 264 nm. The retention time of S and R enantiomers of 1b was 13.9 min and 14.9 min, respectively.
17. Sybyl6.8, Tripos Associates Inc., 1699 S Hanley Rd., St. Louis, MO 631444, USA.
18. Kramer B., Metz G., Rarey M., Lengauer T. Med. Chem. Res. 9:1999;463.
19. www.rcsb.org .
20. Fabiola G.F., Pattabhi V., Nagarajan K. Bioorg. Med. Chem. 6:1998;2337.
21. Noreen Y., Ringbom T., Perera P., Danielson H., Bohlin L. J. Nat. Prod. 61:1998;2.
22. Hiramatsu Y., Akita S., Salamin P.A., Maier R. Arzneimittelforschung/ Drug Res. 40:1990;1117.